ARCHIVES

An “insurgency” targets randomized trials, demands access to investigational drugs.

This article is from The Cancer Letter archive.

Vol. 31 No. 31 | August 5, 2005

Download PDF Visit The Full Archive

Related Articles

More Debate Due On Organ Site Program; First Round Reviewed By DRG “Slaughtered”

January 28, 1983

Grand Jury Clears Eppley, Shubik

October 24, 1980

New Drug Approval: Groups Urge FDA To Move Quickly On Herceptin Approval

September 18, 1998

Cancer Letter Accepts “Substantial” Settlement In New Copyright Claim

August 5, 1988

NIH Authorization Set For Another Try; Women’s Cancers Are Targeted

July 10, 1992

Public Health Service: Scientific Papers Become “Deliverables” In Own RFP

October 3, 1997